Abbott Laboratories (ABT) EPS (Basic) (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of EPS (Basic) data on file, last reported at $0.62 in Q1 2026.

• For the quarter ending Q1 2026, EPS (Basic) fell 18.87% year-over-year to $0.62; the trailing twelve-month figure through Mar 2026 stood at $3.6 (down 53.61% YoY), and the FY2025 full-year result was $3.75, down 51.35% from the prior year.
• EPS (Basic) fell to $0.62 in Q1 2026, from $1.02 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of $5.3 in Q4 2024 to a low of $0.59 in Q4 2022.
• A 5-year average of $1.14 and a median of $0.83 in 2023 frame the typical range for EPS (Basic).
• Across the five-year window, EPS (Basic) jumped 478.98% in 2024 and slumped 80.77% in 2025, its largest moves.
• Tracing ABT's EPS (Basic) over 5 years: stood at $0.59 in 2022, then surged by 55.46% to $0.92 in 2023, then jumped by 478.98% to $5.3 in 2024, then tumbled by 80.77% to $1.02 in 2025, then slumped by 39.41% to $0.62 in 2026.
• Business Quant data shows ABT's EPS (Basic) at $0.62 in Q1 2026, $1.02 in Q4 2025, and $0.94 in Q3 2025.